glp 1 drugs injection GLP1 Drug Use For Weight Loss Has Soared Costing Billions GLP1 pills vs. injections: Which

Description

Dusetzina, PhD, a professor of health policy at Vanderbilt University Medical Center

BioWorld - Saturday, July 18, 2026 Breaking News: Best of BioWorld Science: Q2See today's BioWorld Science Home Innovent gets IND for oral GLP-1 agonist To read the full story, subscribe or sign in

hsCRP (High-Sensitivity C-Reactive Protein) Inflammatory burden is an important driver of metabolic disease and cardiovascular risk

The propensity score was estimated using logistic regression as the probability of starting a GLP1 receptor agonist versus a DPP4 inhibitor conditional on a number of variables, including sociodemographic characteristics, medical history, other diabetes treatment, and markers of healthcare use, at cohort entry and stratified by country (etable 3)